Hepatitis Monthly

Published by: Kowsar

The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan

Norio Itokawa 1 , Masanori Atsukawa 1 , 2 , * , Akihito Tsubota 3 , Hiroshi Abe 4 , Noritomo Shimada 5 , Tomomi Okubo 1 , Taeang Arai 1 , Ai Nakagawa 1 , Chisa Kondo 1 , Yoshio Aizawa 4 and Katsuhiko Iwakiri 2
Authors Information
1 Division of Gastroenterology, Department of Internal Medicine, Nippon Medical School Chiba Hokusoh Hospital, Chiba, Japan
2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan
3 Core Research Facilities for Basic Science, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan
4 Division of Gastroenterology and Hepatology, The Jikei University School of Medicine Katsusika Medical Center, Tokyo, Japan
5 Division of Gastroenterology and Hepatology, Otakanomori Hospital, Kashiwa, Chiba, Japan
Article information
  • Hepatitis Monthly: May 2018, 18 (5); e63587
  • Published Online: May 1, 2018
  • Article Type: Research Article
  • Received: November 3, 2017
  • Revised: March 16, 2018
  • Accepted: March 28, 2018
  • DOI: 10.5812/hepatmon.63587

To Cite: Itokawa N, Atsukawa M, Tsubota A, Abe H, Shimada N, et al. The Relationship Between 25-Hydroxyvitamin D3 and Hepatitis B Surface Antigen Levels in Patients with Chronic Hepatitis B in Japan, Hepat Mon. 2018 ; 18(5):e63587. doi: 10.5812/hepatmon.63587.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. World Health Organization . Hepatitis B. Fact Sheet No.204. 2013.
  • 2. Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359(14):1486-500. doi: 10.1056/NEJMra0801644. [PubMed: 18832247].
  • 3. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 2012;142(5):1140-1149 e3. quiz e13-4. doi: 10.1053/j.gastro.2012.02.007. [PubMed: 22333950].
  • 4. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657-66. doi: 10.1016/S0140-6736(07)61342-7. [PubMed: 17720017].
  • 5. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26(5):662-87. doi: 10.1210/er.2004-0002. [PubMed: 15798098].
  • 6. Manuel Quesada J, Solana R, Serrano I, Barrio V, Martinez ME, Santamaria M, et al. Immunologic effects of vitamin D. N Engl J Med. 1989;321(12):833-4. doi: 10.1056/NEJM198909213211215. [PubMed: 2597268].
  • 7. Salahuddin N, Ali F, Hasan Z, Rao N, Aqeel M, Mahmood F. Vitamin D accelerates clinical recovery from tuberculosis: results of the SUCCINCT Study [Supplementary Cholecalciferol in recovery from tuberculosis]. A randomized, placebo-controlled, clinical trial of vitamin D supplementation in patients with pulmonary tuberculosis'. BMC Infect Dis. 2013;13:22. doi: 10.1186/1471-2334-13-22. [PubMed: 23331510].
  • 8. Ginde AA, Scragg R, Schwartz RS, Camargo CJ. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc. 2009;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. [PubMed: 19549021].
  • 9. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJ. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia. 1995;38(10):1239-45. doi: 10.1007/BF00422375. [PubMed: 8690178].
  • 10. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006;98(7):451-9. doi: 10.1093/jnci/djj101. [PubMed: 16595781].
  • 11. Atsukawa M, Tsubota A, Shimada N, Yoshizawa K, Abe H, Asano T, et al. Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients. BMC Infect Dis. 2015;15:344. doi: 10.1186/s12879-015-1020-y. [PubMed: 26286329].
  • 12. Petta S, Camma C, Scazzone C, Tripodo C, Di Marco V, Bono A, et al. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 2010;51(4):1158-67. doi: 10.1002/hep.23489. [PubMed: 20162613].
  • 13. Atsukawa M, Tsubota A, Shimada N, Kondo C, Itokawa N, Nakagawa A, et al. Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study. Hepat Mon. 2013;13(12). e14872. doi: 10.5812/hepatmon.14872. [PubMed: 24403915].
  • 14. Farnik H, Bojunga J, Berger A, Allwinn R, Waidmann O, Kronenberger B, et al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology. 2013;58(4):1270-6. doi: 10.1002/hep.26488. [PubMed: 23703797].
  • 15. Yu R, Sun J, Zheng Z, Chen J, Fan R, Liang X, et al. Association between vitamin D level and viral load or fibrosis stage in chronic hepatitis B patients from Southern China. J Gastroenterol Hepatol. 2015;30(3):566-74. doi: 10.1111/jgh.12783. [PubMed: 25238258].
  • 16. Chan HL, Elkhashab M, Trinh H, Tak WY, Ma X, Chuang WL, et al. Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B. J Hepatol. 2015;63(5):1086-92. doi: 10.1016/j.jhep.2015.06.025. [PubMed: 26143444].
  • 17. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-81. doi: 10.1056/NEJMra070553. [PubMed: 17634462].
  • 18. Martinez SM, Crespo G, Navasa M, Forns X. Noninvasive assessment of liver fibrosis. Hepatology. 2011;53(1):325-35. doi: 10.1002/hep.24013. [PubMed: 21254180].
  • 19. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Ledinghen V, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int. 2009;29(2):242-7. doi: 10.1111/j.1478-3231.2008.01802.x. [PubMed: 18637064].
  • 20. Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, et al. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2013;23(8):792-8. doi: 10.1016/j.numecd.2012.12.006. [PubMed: 23415456].
  • 21. Targher G, Bertolini L, Scala L, Cigolini M, Zenari L, Falezza G, et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis. 2007;17(7):517-24. doi: 10.1016/j.numecd.2006.04.002. [PubMed: 16928437].
  • 22. Chen EQ, Bai L, Zhou TY, Fe M, Zhang DM, Tang H. Sustained suppression of viral replication in improving vitamin D serum concentrations in patients with chronic hepatitis B. Sci Rep. 2015;5:15441. doi: 10.1038/srep15441. [PubMed: 26486883].
  • 23. Tsiaras WG, Weinstock MA. Factors influencing vitamin D status. Acta Derm Venereol. 2011;91(2):115-24. doi: 10.2340/00015555-0980. [PubMed: 21384086].
  • 24. Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, et al. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol. 2002;40(2):439-45. doi: 10.1128/JCM.40.2.439-445.2002. [PubMed: 11825954].
  • 25. Limothai U, Chuaypen N, Khlaiphuengsin A, Chittmittraprap S, Poovorawan Y, Tangkijvanich P. Association of vitamin-D-related genetic variations and treatment response to pegylated interferon in patients with chronic hepatitis B. Antivir Ther. 2017;22(8):681-8. doi: 10.3851/IMP3154. [PubMed: 28291736].
  • 26. Bandeira F, Griz L, Dreyer P, Eufrazino C, Bandeira C, Freese E. Vitamin D deficiency: A global perspective. Arq Bras Endocrinol Metabol. 2006;50(4):640-6. doi: 10.1590/S0004-27302006000400009. [PubMed: 17117289].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments